Literature DB >> 11445847

The relationship between allelic imbalance on 17p, p53 mutation and p53 overexpression in head and neck cancer.

K Götte1, F Riedel, J Neubauer, C Schäfer, J F Coy, K Hörmann.   

Abstract

The huge majority of head and neck squamous cell carcinoma (HNSCC) show alterations of p53 either on the genetic level or on the protein level. Allelic imbalance (AI)/loss of heterozygosity (LOH) on 17p at the p53 locus is frequent in HNSCC. However, the complex relationship between these phenomena is poorly understood in HNSCC. We investigated one group of 39 HNSCC for: a) allelic imbalance on 17p using 4 microsatellite markers located throughout this chromosomal arm; b) mutations of p53 in exons 5-9; and c) overexpression of p53 using two antibodies located on opposite ends of the protein. AI/LOH was detected in 44% at the locus TP53, rising to 69% when regarding all 4 markers on 17p. Therefore, our data are in line with the assumption of additional tumour suppressor genes on 17p in HNSCC. A nuclear accumulation of p53 (51%) was independent from the antibody and the recognised epitope. At the first glance there was no correlation between overall p53 mutation (36%) and overexpression. However, it appeared that, with very few exceptions, only nonsense mutations did not lead to p53 overexpression, while missense mutations did. As overexpression of p53 was 15% more frequent than p53 mutations and only 35% of the tumours with p53 overexpression carried a p53 mutation, our data support the hypothesis of additional mechanisms of p53 overexpression. AI/LOH at the p53 locus in 83% of all tumours with a p53 mutation is in line with Knudson's theory of inactivation of tumour suppressor genes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11445847

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  5 in total

Review 1.  Molecular mechanisms of head and neck cancer.

Authors:  Amit M Deshpande; David T Wong
Journal:  Expert Rev Anticancer Ther       Date:  2008-05       Impact factor: 4.512

2.  High SEPT9_v1 Expression Is Associated with Poor Clinical Outcomes in Head and Neck Squamous Cell Carcinoma.

Authors:  Laura Stanbery; Nisha J D'Silva; Julia S Lee; Carol R Bradford; Thomas E Carey; Mark E Prince; Gregory T Wolf; Francis P Worden; Kitrina G Cordell; Elizabeth M Petty
Journal:  Transl Oncol       Date:  2010-08-01       Impact factor: 4.243

3.  Biased expression of mutant alleles in cancer-related genes in esophageal squamous cell carcinoma.

Authors:  Masahiko Takahashi; Kazuyoshi Hosomichi; Hirofumi Nakaoka; Haruhito Sakata; Naoya Uesato; Kentaro Murakami; Masayuki Kano; Takeshi Toyozumi; Yasunori Matsumoto; Tetsuro Isozaki; Nobufumi Sekino; Ryota Otsuka; Itsuro Inoue; Hisahiro Matsubara
Journal:  Esophagus       Date:  2022-01-11       Impact factor: 4.230

4.  Molecular heterogeneity in malignant peripheral nerve sheath tumors associated with neurofibromatosis type 1.

Authors:  Laura Thomas; Victor-Felix Mautner; David N Cooper; Meena Upadhyaya
Journal:  Hum Genomics       Date:  2012-09-04       Impact factor: 4.639

5.  Genome-Wide Loss of Heterozygosity and DNA Copy Number Aberration in HPV-Negative Oral Squamous Cell Carcinoma and Their Associations with Disease-Specific Survival.

Authors:  Chu Chen; Yuzheng Zhang; Melissa M Loomis; Melissa P Upton; Pawadee Lohavanichbutr; John R Houck; David R Doody; Eduardo Mendez; Neal Futran; Stephen M Schwartz; Pei Wang
Journal:  PLoS One       Date:  2015-08-06       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.